リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Protein C activity as a potential prognostic factor for nursing home-acquired pneumonia」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Protein C activity as a potential prognostic factor for nursing home-acquired pneumonia

Oi, Issei Ito, Isao Tanabe, Naoya Konishi, Satoshi Hamao, Nobuyoshi Shirata, Masahiro Imai, Seiichiro Yasutomo, Yoshiro Kadowaki, Seizo Matsumoto, Hisako Hidaka, Yu Morita, Satoshi Hirai, Toyohiro 京都大学 DOI:10.1371/journal.pone.0274685

2022.10.12

概要

[Introduction] Despite the poor prognosis for nursing home acquired pneumonia (NHAP), a useful prognostic factor is lacking. We evaluated protein C (PC) activity as a predictor of in-hospital death in patients with NHAP and community-acquired pneumonia (CAP). [Methods] This prospective, observational study included all patients hospitalized with pneumonia between July 2007 and December 2012 in a single hospital. We measured PC activity at admission and investigated whether it was different between survivors and non-survivors. We also examined whether PC activity < 55% was a predictor for in-hospital death of pneumonia by logistic regression analysis with CURB-65 items (confusion, blood urea >20 mg/dL, respiratory rate >30/min, and blood pressure <90/60 mmHg, age >65). When it was a useful prognostic factor for pneumonia, we combined PC activity with the existing prognostic scores, the pneumonia severity index (PSI) and CURB-65, and analyzed its additional effect by comparing the areas under the receiver operating characteristic curves (AUCs) of the modified and original scores. [Results] Participants comprised 75 NHAP and 315 CAP patients. PC activity was lower among non-survivors than among survivors in NHAP and all-pneumonia (CAP+NHAP). PC activity <55% was a useful prognostic predictor for NHAP (Odds ratio 7.39 (95% CI; 1.59–34.38), and when PSI or CURB-65 was combined with PC activity, the AUC improved (from 0.712 to 0.820 for PSI, and 0.657 to 0.734 for CURB-65). [Conclusions] PC activity was useful for predicting in-hospital death of pneumonia, especially in NHAP, and became more useful when combined with the PSI or CURB-65.

論文の公開元へ

この論文で使われている画像

関連論文

関連論文をもっと見る

参考文献

1. Tamiya N, Yamaoka K, Yano E. Use of home health services covered by new public long-term care insurance in Japan: Impact of the presence and kinship of family caregivers. Int J Qual Heal Care 2002; 14:295–303. https://doi.org/10.1093/intqhc/14.4.295 PMID: 12201188

2. Kodama H, Izumo Y, Takahashi R, Suda Y, Kudo H, Kudo H, et al. Family relationships of self-care- dependent older people and institutionalized rate to nursing homes. Geriatr Gerontol Int 2009; 9:320–5. https://doi.org/10.1111/j.1447-0594.2009.00536.x PMID: 19702944

3. Mylotte JM. Nursing Home-Associated Pneumonia. Clin Geriatr Med 2007; 23:553–65. https://doi.org/ 10.1016/j.cger.2007.02.003 PMID: 17631233

4. Lopes M, Silva GA, Nogueira RF, Marado D, Goncalves J, Athayde C, et al. Incidence of antibiotic treat- ment failure in patients with nursing home-acquired pneumonia and community acquired pneumonia. Infect Dis Rep 2021; 13:33–44. https://doi.org/10.3390/idr13010006 PMID: 33466353

5. Maruyama T, Gabazza EC, Morser J, Takagi T, D’Alessandro-Gabazza C, Hirohata S, et al. Commu- nity-acquired pneumonia and nursing home-acquired pneumonia in the very elderly patients. Respir Med 2010; 104:584–92. https://doi.org/10.1016/j.rmed.2009.12.008 PMID: 20060700

6. Peterson PK, Stein D, Guay DRP, Logan G, Obaid S, Gruninger R, et al. Prospective study of lower respiratory tract infections in an extended-care nursing home program: Potential role of oral ciprofloxa- cin. Am J Med 1988; 85:164–71. https://doi.org/10.1016/s0002-9343(88)80336-x PMID: 3041830

7. Marrie TJ, Durant H, Kwan C. Nursing Home-Acquired Pneumonia: A Case-Control Study. J Am Geriatr Soc 1986; 34:697–702. https://doi.org/10.1111/j.1532-5415.1986.tb04300.x.

8. Marrie TJ, Blanchard W. A comparison of nursing home-acquired pneumonia patients with patients with community-acquired pneumonia and nursing home patients without pneumonia. J Am Geriatr Soc 1997; 45:50–5. https://doi.org/10.1111/j.1532-5415.1997.tb00977.x PMID: 8994487

9. Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: 5-year pro- spective study. Rev Infect Dis 1989; 11:586–99. https://doi.org/10.1093/clinids/11.4.586 PMID: 2772465

10. Lim WS, Macfarlane JT. A prospective comparison of nursing home acquired pneumonia with commu- nity acquired pneumonia. Eur Respir J 2001; 18:362–8. https://doi.org/10.1183/09031936.01.00204401 PMID: 11529297

11. Polverino E, Dambrava P, Cillo´niz C, Balasso V, Marcos MA, Esquinas C, et al. Nursing home-acquired pneumonia: A 10 year single-centre experience. Thorax 2010; 65:354–9. https://doi.org/10.1136/thx. 2009.124776 PMID: 20388763

12. Garb J L, Brown R B, Garb RWT J R. Differences in etiology of pneumonias in nursing home and com- munity patients. JAMA 1978:2169–72. https://pubmed.ncbi.nlm.nih.gov/359845/ (accessed April 28, 2021).

13. Umeki K, Tokimatsu I, Yasuda C, Iwata A, Yoshioka D, Ishii H, et al. Clinical features of healthcare- associated pneumonia (HCAP) in a Japanese community hospital: Comparisons among nursing home- acquired pneumonia (NHAP), HCAP other than NHAP, and community-acquired pneumonia. Respirol- ogy 2011; 16:856–61. https://doi.org/10.1111/j.1440-1843.2011.01983.x.

14. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336:243–50. https://doi.org/ 10.1056/NEJM199701233360402 PMID: 8995086

15. Lim WS, Van Der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: An international derivation and validation study. Thorax 2003; 58:377–82. https://doi.org/10.1136/thorax.58.5.377 PMID: 12728155

16. Berg P, Lindhardt BØ. The role of procalcitonin in adult patients with community-acquired pneumonia— A systematic review. Dan Med J 2012; 59. PMID: 22381083

17. B.J. N, J.M. M, A. T. Outcome of nursing home-acquired pneumonia: Derivation and application of a practical model to predict 30 day mortality. J Am Geriatr Soc 2000; 48:1292–9. https://doi.org/10.1111/j. 1532-5415.2000.tb02604.x PMID: 11037018

18. Lee JC, Hwang HJ, Park YH, Joe JH, Chung JH, Kim SH. Comparison of severity predictive rules for hospitalised nursing home-acquired pneumonia in korea: A retrospective observational study. Prim Care Respir J 2013; 22:149–54. https://doi.org/10.4104/pcrj.2013.00011 PMID: 23494188

19. Porfyridis I, Georgiadis G, Vogazianos P, Mitis G, Georgiou A. C-reactive protein, procalcitonin, clinical pulmonary infection score, and pneumonia severity scores in nursing home acquired pneumonia. Respir Care 2014; 59:574–81. https://doi.org/10.4187/respcare.02741 PMID: 24106319

20. Kim SH, Chung JH, Lee JC, Park YH, Joe JH, Hwang HJ. Carboxy-terminal provasopressin may predict prognosis in nursing home acquired pneumonia. Clin Chim Acta 2013; 421:226–9. https://doi.org/10. 1016/j.cca.2013.02.022 PMID: 23454473

21. Esmon CT, Taylor FB, Snow TR. Inflammation and Coagulation: Linked Processes Potentially Regu- lated Through a Common Pathway Mediated by Protein C. Thromb Haemost 1991; 66:160–5. https:// doi.org/10.1055/s-0038-1646385. PMID: 1833850

22. Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A, et al. Septic shock, multiple organ failure, and disseminated intravascular coagulation; Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992; 101:816–23. https://doi.org/10.1378/chest.101.3.816.

23. Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci U S A 1981; 78:2249–52. https://doi.org/10.1073/pnas.78.4.2249 PMID: 7017729

24. Esmon CT. Protein S and protein C. Biochemistry, physiology, and clinical manifestation of deficiencies. Trends Cardiovasc Med 1992; 2:214–9. https://doi.org/10.1016/1050-1738(92)90027-P.

25. Macias WL, Nelson DR. Severe protein C deficiency predicts early death in severe sepsis. Crit Care Med 2004; 32:223–8. https://doi.org/10.1097/01.ccm.0000126120.49367.ac PMID: 15118522

26. Shorr AF, Bernard GR, Dhainaut JF, Russell JR, Macias WL, Nelson DR, et al. Protein C concentrations in severe sepsis: An early directional change in plasma levels predicts outcome. Crit Care 2006; 10:1–8. https://doi.org/10.1186/cc4946 PMID: 16780598

27. Shaw AD, Vail GM, Haney DJ, Xie J, Williams MD. Severe protein C deficiency is associated with organ dysfunction in patients with severe sepsis. J Crit Care 2011; 26:539–45. https://doi.org/10.1016/j.jcrc. 2011.05.006 PMID: 21737232

28. Lorente JA, Garcia-Frade LJ, Landin L, De Pablo R, Torrado C, Renes E, et al. Time course of hemo- static abnormalities in sepsis and its relation to outcome. Chest 1993; 103:1536–42. https://doi.org/10. 1378/chest.103.5.1536 PMID: 8486040

29. Hesselvik JF, Malm J, Dahlba¨ ck B, Blomba¨ ck M. Protein C, protein S and C4b-binding protein in severe infection and septic shock. Thromb Haemost 1991; 65:126–9. PMID: 1828915

30. Yan SB, Helterbrand JD, Hartman DL, Wright TJ, Bernard GR. Low levels of protein C are associated with poor outcome in severe sepsis. Chest 2001; 120:915–22. https://doi.org/10.1378/chest.120.3.915 PMID: 11555529

31. Shorr AF, Nelson DR, Wyncoll DLA, Reinhart K, Brunkhorst F, Vail G, et al. Protein C: A potential bio- marker in severe sepsis and a possible tool for monitoring treatment with drotrecogin alfa (activated). Crit Care 2008; 12:1–11. https://doi.org/10.1186/cc6854 PMID: 18394162

32. Brunkhorst F, Sakr Y, Hagel S, Reinhart K. Protein C concentrations correlate with organ dysfunction and predict outcome independent of the presence of sepsis. Anesthesiology 2007; 107:15–23. https:// doi.org/10.1097/01.anes.0000267531.39410.d3 PMID: 17585211

33. Matthay MA, Ware LB. Plasma protein C levels in patients with acute lung injury: prognostic signifi- cance. Crit Care Med 2004; 32:229–32. https://doi.org/10.1097/01.ccm.0000126121.56990.d3 PMID: 15118523

34. Ware LB, Fang X, Matthay MA. Protein C and thrombomodulin in human acute lung injury. Am J Physiol—Lung Cell Mol Physiol 2003; 285:514–21. https://doi.org/10.1152/ajplung.00442.2002 PMID: 12754194

35. Sapru A, Wiemels JL, Witte JS, Ware LB, Matthay MA. Acute lung injury and the coagulation pathway: Potential role of gene polymorphisms in the protein C and fibrinolytic pathways. Intensive Care Med 2006; 32:1293–303. https://doi.org/10.1007/s00134-006-0223-5 PMID: 16770611

36. Ito I, Kadowaki S, Tanabe N, Haruna A, Kase M, Yasutomo Y, et al. Tazobactam/piperacillin for moder- ate-to-severe pneumonia in patients with risk for aspiration: Comparison with imipenem/cilastatin. Pulm Pharmacol Ther 2010; 23:403–10. https://doi.org/10.1016/j.pupt.2010.05.007 PMID: 20561917

37. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996; 49:1373–9. https://doi.org/10.1016/ s0895-4356(96)00236-3 PMID: 8970487

38. Stenflo J. A new vitamin K-dependent protein. Purification from bovine plasma and preliminary charac- terization. J Biol Chem 1976; 251:355–63. PMID: 1245477

39. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699–709. https://doi.org/10.1056/NEJM200103083441001 PMID: 11236773

40. Toussaint S, Gerlach H. Activated protein C for sepsis. N Engl J Med 2009; 361:2646–52. https://doi. org/10.1056/NEJMct0808063 PMID: 20042756

41. Feistritzer C, Riewald M. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood 2005; 105:3178–84. https://doi.org/10. 1182/blood-2004-10-3985 PMID: 15626732

42. Stephens LC, Kotulak GD, Reed EC, Vose JM, Bierman PJ, Kessinger A, et al. Multiple Organ Dysfunc- tion Syndrome in Bone Marrow Transplantation. JAMA J Am Med Assoc 1995; 274:1289–95. https:// doi.org/10.1001/jama.1995.03530160041031. PMID: 7563534

43. Boldt J, Papsdorf M, Rothe A, Kumle B, Piper S. Changes of the hemostatic network in critically ill patients—Is there a difference between sepsis, trauma, and neurosurgery patients? Crit Care Med 2000; 28:445–50. https://doi.org/10.1097/00003246-200002000-00026 PMID: 10708181

44. Lee JH, Kim J, Kim K, Jo YH, Rhee JE, Kim TY, et al. Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia. J Crit Care 2011; 26:287–94. https://doi. org/10.1016/j.jcrc.2010.10.007 PMID: 21129911

45. Viasus D, Garcia-Vidal C, Simonetti A, Manresa F, Dorca J, Gudiol F, et al. Prognostic value of serum albumin levels in hospitalized adults with community-acquired pneumonia. J Infect 2013; 66:415–23. https://doi.org/10.1016/j.jinf.2012.12.007 PMID: 23286966

46. Marrie TJ, Fine MJ, Kapoor WN, Coley CM, Singer DE, Scott D. Community-Acquired Pneumonia and Do Not Resuscitate Orders. vol. 50. 2002.

47. Ugajin M, Yamaki K, Hhirasawa N, Kobayashi T, Yagi T. Prognostic value of severity indicators of nurs- ing-home-acquired pneumonia versus community-acquired pneumonia in elderly patients. Clin Interv Aging 2014; 9:267–74. https://doi.org/10.2147/CIA.S58682 PMID: 24611004

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文
を
一発検索！

この論文の関連論文を見る